Japan's Taisho Establishes Global OTC Footprint With $1.6bn Acquisition of Bristol-Myers Squibb's UPSA

HBW1812_Network Map_1091222291_1200.jpg
Taisho is building a global consumer health operation with UPSA • Source: Shutterstock
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business